The homepage names semaglutide under weight-loss compounding.
Tirzepatide
The homepage names tirzepatide under weight-loss compounding.
First-party formulation references do not establish availability in every state or for every patient.
Locations in the source record
16011 N. Nebraska Ave, Suite 103, Lutz, FL 33549
Services named by sources
Patient-specific 503A compounding
Weight-management compounding
Same-day prescription fulfillment
Cold-chain delivery
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
Absolute describes its patient-specific compounding as 503A, and FDA's compounding-action index identifies the Lutz facility as a 503A facility. Section 503A is a statutory compounding pathway, not an FDA registration.
Section 503B
Not conclusively established
FDA's action index says the entity was de-registered as an outsourcing facility. Current 503B status remains null; the client-rendered current registry was not exhaustively searchable in this run.
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
FDA compounding-action, state-referral, Form 483 and current 503B-registry searches were checked. The Florida license record showed no discipline on file. Other state-board action searches were not completed.
U.S. Food and Drug Administration · 2017-02-15
State Referral Letter
FDA referred sterile-practice concerns observed during a March 21-April 11, 2016 inspection to the Florida Board of Pharmacy. The letter describes inspectional observations; it is not a warning letter or a final agency determination.
The purpose of this letter is to refer to the Florida State Board of Pharmacy (BOP) for appropriate follow up, the U.S. Food and Drug Administration's (FDA) concerns about poor sterile practices observed during an FDA inspection at a pharmacy licensed by the Florida BOP, Absolute Pharmacy, LLC
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 8 dated first-party or regulator citation(s), 1 regulatory/action record(s), and 3 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
Know when GLP-1 prices move.
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.